High risk in E/M evaluation includes which statement?

High risk in E/M evaluation includes which statement?

• A. High risk of morbidity from additional dx testing or treatment
• B. Low risk of morbidity with observation
• C. Moderate risk with non-invasive imaging
• D. Minimal risk with routine follow-up

Answer: (A)

In E/M evaluation, risk level is about how dangerous the patient's condition would be if not treated promptly. High risk means there is a significant probability of morbidity or mortality, including scenarios where the risk arises from the need for additional diagnostic testing or treatment. The statement describing a high risk of morbidity from further testing or therapy fits this definition because choosing to pursue more tests or start treatments can carry substantial potential harm, serious adverse effects, or complications, and delaying care could worsen outcomes. The other options describe lower levels of risk: observation with the expectation of low morbidity, non-invasive imaging with moderate risk, and routine follow-up with minimal risk. Each aligns with its respective risk category, but none convey the high-stakes potential of morbidity or mortality that prompts more intensive management in the E/M framework.

In E/M evaluation, risk level is about how dangerous the patient's condition would be if not treated promptly. High risk means there is a significant probability of morbidity or mortality, including scenarios where the risk arises from the need for additional diagnostic testing or treatment. The statement describing a high risk of morbidity from further testing or therapy fits this definition because choosing to pursue more tests or start treatments can carry substantial potential harm, serious adverse effects, or complications, and delaying care could worsen outcomes.

The other options describe lower levels of risk: observation with the expectation of low morbidity, non-invasive imaging with moderate risk, and routine follow-up with minimal risk. Each aligns with its respective risk category, but none convey the high-stakes potential of morbidity or mortality that prompts more intensive management in the E/M framework.